✦ LIBER ✦

DIGamber: a digital design and diagnostic tool in expert system environment

✍ Scribed by P. Pourbeik; L.C. Jain

Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 339 KB
Volume: 24
Category: Article
ISSN: 0026-2692
DOI: 10.1016/0026-2692(93)90156-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DIGamber: a digital design and diagnosti

DIGamber: a digital design and diagnostic tool in expert system environment : P. Pourbeik and L. C. Jain. Microelectronics Journal, 24, 253 (1993)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Information and expert system interactio

Information and expert system interaction in a hospital environment

✍ A. Fandák; M. Popper; M. Guregová; K. Fandáková; M. Sýkora 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 313 KB

A combined S-transform and fuzzy expert

A combined S-transform and fuzzy expert system for phase selection in digital relaying

✍ S. R. Samantaray; P. K. Dash; G. Panda 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

The design, implementation and evaluatio

The design, implementation and evaluation of a diagnostic expert system for the work order procedure for small manufacturing companies

✍ Kristin Kennedy; David Shao 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 452 KB

Digital system diagnostics-design/evalua

Digital system diagnostics-design/evaluation : Gregory A. Conley, Proc. Annual Reliability and Maintainability Symposium, San Francisco, p. 38. (22–24 January 1980)

📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Design and implementation of an activity

Design and implementation of an activity-based costing system in a pharmaceutical drug discovery environment

✍ Bernard Coulie; Nadine De Decker; Vic Maes; Filip Roodhooft 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

## Abstract Research and Development investments in the pharmaceutical industry are continuously increasing, resulting in mounting pressure to improve efficiency in terms of output versus cost. Overall, traditional cost accounting methods do not improve effectiveness of pharmaceutical development a